Yield10 Bioscience Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 42

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $5M

Yield10 Bioscience General Information

Description

Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.

Contact Information

Formerly Known As
Metabolix
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 19 Presidential Way
  • Woburn, MA 01801
  • United States
Primary Industry
Other Agriculture
Other Industries
Biotechnology
Specialty Chemicals
Acquirer
Nuseed Global
Corporate Office
  • 19 Presidential Way
  • Woburn, MA 01801
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yield10 Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
23. Merger/Acquisition 01-Jan-2025 $5M Completed Generating Revenue/Not Profitable
22. Bankruptcy: Admin/Reorg 06-Dec-2024 Completed Bankruptcy: Admin/Reorg
21. 2PO 09-May-2024 Cancelled Generating Revenue
20. PIPE 15-Aug-2023 Completed Generating Revenue
19. PIPE 26-Aug-2020 Completed Generating Revenue
18. PIPE 19-Nov-2019 Completed Generating Revenue
17. 2PO 18-Nov-2019 Completed Generating Revenue
16. PIPE 18-Mar-2019 Completed Generating Revenue
15. PIPE 03-Jul-2017 $2.3M $173M Completed Generating Revenue
14. Secondary Transaction - Open Market $171M Completed Generating Revenue
To view Yield10 Bioscience’s complete valuation and funding history, request access »

Yield10 Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed
Other Agriculture
Woburn, MA
42 As of 2025

Emeryville, CA
 

Visalia, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Yield10 Bioscience Competitors (5)

One of Yield10 Bioscience’s 5 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Edeniq Venture Capital-Backed Visalia, CA
Ecovia Bio Venture Capital-Backed Livonia, MI
Cibus (Agriculture) Formerly VC-backed San Diego, CA
Viaspace Corporation Santa Cruz, CA
You’re viewing 5 of 5 competitors. Get the full list »

Yield10 Bioscience Patents

Yield10 Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024102881-A1 Transgenic camelina plants genetically modified to be tolerant to glufosinate without exhibiting a decrease in seed yield Inactive 11-Nov-2022
CA-3188488-A1 Genetically modified plants that exhibit an increase in seed yield comprising a first biotin attachment domain-containing (badc) gene homozygous for wild-type allele, a second badc gene homozygous for mutant allele, and homologs of the first and second badc gene Pending 12-Aug-2020
WO-2022036078-A1 Genetically modified plants that exhibit an increase in seed yield comprising a first biotin attachment domain-containing (badc) gene homozygous for wild-type allele, a second badc gene homozygous for mutant allele, and homologs of the first and second badc genes Inactive 12-Aug-2020
AU-2021224206-A1 Genetically engineered plants that express 6-phosphogluconate dehydratase and/or 2-keto-3-deoxy-6-phosphogluconate aldolase Inactive 20-Feb-2020
CA-3170510-A1 Genetically engineered plants that express 6-phosphogluconate dehydratase and/or 2-keto-3-deoxy-6-phosphogluconate aldolase Pending 20-Feb-2020 C12N9/88
To view Yield10 Bioscience’s complete patent history, request access »

Yield10 Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yield10 Bioscience Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Archer Daniels Midland Corporation Minority
Aspire Capital PE/Buyout Minority
Birchview Capital Hedge Fund Minority
Hong Kong Sino-Science Oil & Gas PE/Buyout Minority
Maniv Bioventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Yield10 Bioscience ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Chemicals

Industry

Rank

Percentile

Specialty Chemicals

Subindustry

Rank

Percentile

To view Yield10 Bioscience’s complete esg history, request access »

Yield10 Bioscience FAQs

  • When was Yield10 Bioscience founded?

    Yield10 Bioscience was founded in 1992.

  • Where is Yield10 Bioscience headquartered?

    Yield10 Bioscience is headquartered in Woburn, MA.

  • What is the size of Yield10 Bioscience?

    Yield10 Bioscience has 42 total employees.

  • What industry is Yield10 Bioscience in?

    Yield10 Bioscience’s primary industry is Other Agriculture.

  • Is Yield10 Bioscience a private or public company?

    Yield10 Bioscience is a Private company.

  • What is the current valuation of Yield10 Bioscience?

    The current valuation of Yield10 Bioscience is .

  • What is Yield10 Bioscience’s current revenue?

    The current revenue for Yield10 Bioscience is .

  • How much funding has Yield10 Bioscience raised over time?

    Yield10 Bioscience has raised $193M.

  • Who are Yield10 Bioscience’s investors?

    Archer Daniels Midland, Aspire Capital, Birchview Capital, Hong Kong Sino-Science Oil & Gas, and Maniv Bioventures are 5 of 8 investors who have invested in Yield10 Bioscience.

  • Who are Yield10 Bioscience’s competitors?

    Amyris (Biotechnology), Edeniq, Ecovia Bio, Cibus (Agriculture), and Viaspace are competitors of Yield10 Bioscience.

  • When was Yield10 Bioscience acquired?

    Yield10 Bioscience was acquired on 01-Jan-2025.

  • Who acquired Yield10 Bioscience?

    Yield10 Bioscience was acquired by Nuseed Global.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process